The High Court has agreed to weigh in on a 16-year battle between the federal government and French drug maker Sanofi-Aventis over an allegedly unjustified […]
Nuix had information in January 2021 which undermined the growth story presented to the market in the prospectus for its IPO, a court has heard […]
Ernst & Young has won a temporary stay of a lawsuit by Billabong founder Gordon Merchant alleging the firm gave negligent advice on how to […]
Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns […]
As it readies its civil penalty suit against tech company Nuix for trial, ASIC has flagged a possible dispute about the extent of penalty privilege […]
Global law firm Jones Day has recruited two partners for its growing energy practice, including a former Ashurst partner. Simon Brown will be based in […]
A 16-year battle between the federal government and drug maker Sanofi-Aventis over an allegedly unjustified court order that prevented the release of a generic version […]
Jones Day has added a corporate transactions counsel who spent 12 years working in New York, most recently at Latham & Watkins LLP, to join […]
Companies could be on the hook for higher penalties for foreign bribery and other white collar offences after a High Court majority on Wednesday found […]
A judge has upheld findings from IP Australia that South Korean biotech ToolGen’s genome editing technology CRISPR is not patentable, but given the company one […]